474 results on '"D'Offizi, Gianpiero"'
Search Results
2. Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination
3. Role of the Immune System in Hepatocellular Carcinoma
4. Epidemiology of ventilator-associated pneumonia in ICU COVID-19 patients: an alarming high rate of multidrug-resistant bacteria
5. Proteomic analysis identifies a signature of disease severity in the plasma of COVID-19 pneumonia patients associated to neutrophil, platelet and complement activation
6. Analysis of HIV quasispecies and virological outcome of an HIV D+/R+ kidney–liver transplantation
7. Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia
8. Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital
9. RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies
10. Torquetenovirus Loads in Peripheral Blood Predict Both the Humoral and Cell-Mediated Responses to SARS-CoV-2 Elicited by the mRNA Vaccine in Liver Transplant Recipients
11. Continuing our work: transplant surgery and surgical oncology in a tertiary referral COVID-19 center
12. Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study
13. Phylogenetic and Phylodynamic Analysis of Delta Strains Circulating in Italy
14. Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome
15. Dendritic cells activation is associated with sustained virological response to telaprevir treatment of HCV-infected patients
16. Evolution of SARS‐CoV‐2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID‐19 in an Italian reference hospital: Impact on clinical outcomes
17. Humoral Immune Response after COVID-19 mRNA Vaccination in Patients with Liver Cirrhosis: A Prospective Real-Life Single Center Study
18. Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination
19. Third dose of SARS‐CoV2 mRNA vaccination produces robust persistent cellular and humoral immune responses in liver transplant recipients
20. The impact of the coronavirus disease 2019 pandemic on a central Italy transplant center
21. Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel
22. Publisher Correction: Liver sinusoidal endothelial cells (LSECs) modifications in patients with chronic hepatitis C
23. Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program
24. Forecasting the long‐term impact of COVID‐19 on hepatitis C elimination plans in Italy: A mathematical modelling approach.
25. "Real world" efficacy of bulevirtide in HBV/HDV‐related cirrhosis including people living with HIV: Results from the compassionate use programme at INMI Spallanzani in Rome, Italy.
26. Virological and Clinical Outcomes of Patients with Hdv-Related Compensated Cirrhosis Treated with Bulevirtide Monotherapy: The Retrospective Multicenter European Study (Save-D)
27. Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy; Results of 2 Phase II Multicenter Studies
28. Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post‐transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study
29. Liver sinusoidal endothelial cells (LSECs) modifications in patients with chronic hepatitis C
30. Aero-Medical Evacuation during SARS-CoV-2 Pandemic: Extraordinary Measure or Emerging Treatment Option?
31. Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation
32. Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: Potent antiviral activity but no clinical benefit if treatment is given late
33. Laparoscopic liver resections in normal and cirrhotic livers: A retrospective analysis in a tertiary hepato-biliary unit
34. Effectiveness and safety of simeprevir-based regimens for hepatitis C in Italy: The STIly observational study
35. Reliability and Clinical Relevance of the HIV-1 Drug Resistance Test in Patients With Low Viremia Levels
36. Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study
37. Timing and outcomes of noninvasive ventilation in 307 ARDS COVID-19 patients: an observational study in an Italian third level COVID-19 hospital
38. In HIV/HCV Coinfected Patients Dendritic Cell Activation State Is Not Associated With IL28B Genotype
39. Additional file 1 of Proteomic analysis identifies a signature of disease severity in the plasma of COVID-19 pneumonia patients associated to neutrophil, platelet and complement activation
40. Aero-Medical Evacuation during SARS-CoV-2 Pandemic: Extraordinary Measure or Emerging Treatment Option?
41. Characteristics and Outcomes of COVID-19-Related Hospitalization among PLWH
42. In vitro Evaluation of Antiviral Efficacy of a Standardized Hydroalcoholic Extract of Poplar Type Propolis Against SARS-CoV-2
43. Deep Sequencing of Plasma and Proviral HIV-1 to Establish Coreceptor Usage: What Is the Clinical Impact of the Quasispecies Distribution?
44. High prevalence of asymptomatic SARS-CoV-2 infection in a cohort of Liver Transplant Recipients in Central Italy
45. Fibrogenic signals persist in DAA-treated HCV patients after sustained virological response
46. Coordinated cellular and humoral immune responses after two‐dose SARS‐CoV2 mRNA vaccination in liver transplant recipients
47. Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Combination Therapy in Patients With Coronavirus Disease 2019 and Primary Antibody Deficiency
48. Levels of Interleukin-15 in Plasma May Predict a Favorable Outcome of Structured Treatment Interruption in Patients with Chronic Human Immunodeficiency Virus Infection
49. Acute Human Immunodeficiency Virus Replication Causes a Rapid and Persistent Impairment of Vγ9Vδ2 T Cells in Chronically Infected Patients Undergoing Structured Treatment Interruption
50. Phylogenetic and Phylodynamic Analyses of HCV Strains Circulating among Patients Using Injectable Drugs in Central Italy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.